XML 12 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Operating activities    
Net loss for basic and diluted loss per share available to common stockholders $ (61,959) $ (57,402)
Adjustments to reconcile net loss to net cash proceeds from (used for) operating activities:    
Depreciation and amortization 2,037 2,073
Amortization of debt issuance costs and debt discount 63 1
Non-cash operating lease cost 365 156
Stock-based compensation 7,171 7,307
Loss on derivative liability 15,741 5,335
Allocated expenses for warrant issuance cost 2,526 0
Change in fair value of debt and liability instruments 10,004 3,748
Other 53 (20)
Changes in operating assets and liabilities:    
Accounts receivables, net (3,407) (6,332)
Inventory 1,138 (1,732)
Prepaid expenses and other 474 (9)
Other long-term assets (30) 804
Accounts payable 653 4,334
Accrued Payroll 1,392 1,398
Accrued expenses 470 1,525
Accrued rebates and fees 35,405 16,886
Other liabilities (402) 705
Other long-term liabilities 8 6
Net cash proceeds from (used for) operating activities 11,702 (21,217)
Investing activities    
Acquisition consideration paid in cash for Romeg intangible asset acquisition (300) 0
Purchase of property, plant, and equipment 0 (8)
Net cash used for investing activities (300) (8)
Financing activities    
Proceeds from issuance of shares under Standby Equity Purchase Agreements and ATM Sales Agreement 156 16,166
Proceeds from issuance of Convertible Debentures 0 24,000
Proceeds from issuance of Revolving Facility 65,470 17,538
Proceeds from issuance of FSF Deposit 10,000 0
Repayment of Revolving Facility (65,265) (1,243)
Repayment of Oramed Note (35,000) 0
Transaction costs paid related to the Business Combination 0 (1,372)
Repayment of Convertible Debentures (4,375) (1,285)
Payments of debt issuance costs 0 (380)
Proceeds from issuance of shares under Bought Deal Offering and Registered Direct Offering 25,000 0
Payments of Bought Deal Offering and Registered Direct Offering issuance costs (2,834) 0
Proceeds from stock options and warrants exercised 383 743
Net cash (used for) proceeds from financing activities (6,465) 54,167
Net change in cash, cash equivalents and restricted cash 4,937 32,942
Cash and cash equivalents at beginning of period 4,729 2,184
Cash and cash equivalents at end of period 9,666 35,126
Supplemental disclosure of non-cash financing activity    
Issuance of shares to B.Riley pursuant to B. Riley Purchase Agreement 0 1,869
Issuance costs related to Bought Deal Offering and Registered Direct included in accrued expenses and account payables 1,440 0
Conversion of Convertible Debentures into common stock 0 7,735
Right-of-use assets obtained in exchange for operating lease liabilities with lease modification $ 0 $ 2,523